| # | Drug | Count |
|---|---|---|
| 0 | RANITIDINE | 17674 |
| 1 | RANITIDINE HYDROCHLORIDE | 5102 |
| 2 | REGORAFENIB | 286 |
| 3 | PANITUMUMAB | 252 |
| 4 | VALSARTAN | 195 |
| 5 | FLUOROURACIL | 189 |
| 6 | FLUOROURACIL CREAM, 0.5% | 187 |
| 7 | VALSARTAN ORAL | 180 |
| 8 | OXALIPLATIN | 137 |
| 9 | ADALIMUMAB | 123 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | RANITIDINE HYDROCHLORIDE | 5102 | 0.0942 |
| 1 | RANITIDINE | 17674 | 0.0893 |
| 2 | AMLODIPINE, VALSARTAN AND HYDROCHLOROTHIAZIDE | 2 | 0.0400 |
| 3 | REGORAFENIB | 286 | 0.0246 |
| 4 | PANITUMUMAB | 252 | 0.0156 |
| 5 | OLOPATADINE HCL | 4 | 0.0110 |
| 6 | LEVOLEUCOVORIN INJECTION | 28 | 0.0091 |
| 7 | LEVOLEUCOVORIN | 28 | 0.0073 |
| 8 | FRUQUINTINIB | 27 | 0.0069 |
| 9 | AMLODIPINE AND VALSARTAN | 1 | 0.0051 |
| # | Drug class | Count |
|---|---|---|
| 0 | Epidermal Growth Factor Receptor Antagonist [EPC] | 277 |
| 1 | Nucleoside Metabolic Inhibitor [EPC] | 268 |
| 2 | Angiotensin 2 Receptor Blocker [EPC] | 214 |
| 3 | Corticosteroid [EPC] | 183 |
| 4 | Tumor Necrosis Factor Blocker [EPC] | 177 |
| 5 | Platinum-based Drug [EPC] | 144 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 125 |
| 7 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 114 |
| 8 | Proton Pump Inhibitor [EPC] | 85 |
| 9 | Loop Diuretic [EPC] | 78 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Epidermal Growth Factor Receptor Antagonist [EPC] | 277 | 0.0059 |
| 1 | Glucosylceramide Synthase Inhibitor [EPC] | 3 | 0.0011 |
| 2 | Nucleoside Metabolic Inhibitor [EPC] | 268 | 0.0010 |
| 3 | Non-Standardized Fungal Allergenic Extract [EPC] | 2 | 0.0009 |
| 4 | GLP-2 Analog [EPC] | 12 | 0.0009 |
| 5 | Allylamine Antifungal [EPC] | 5 | 0.0007 |
| 6 | Angiotensin 2 Receptor Blocker [EPC] | 214 | 0.0007 |
| 7 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 114 | 0.0006 |
| 8 | Phenothiazine [EPC] | 16 | 0.0005 |
| 9 | Platinum-based Drug [EPC] | 144 | 0.0005 |